- Research works
- 1 fractional, all time
- Citations
- 26 18.4 per fractional work
- Top-10% rate
- 2.8% record average 16.5%
- Open access
- 15% world 28%
Not ranked overall: Centro de Investigación Médica Aplicada is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Centro de Investigación Médica Aplicada publish most on?
By volume: Eicosanoids and Hypertension Pharmacology, Hormonal Regulation and Hypertension, CRISPR and Genetic Engineering and MicroRNA in disease regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Eicosanoids and Hypertension Pharmacology Biochemistry 0 works
- 2 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 0 works
- 3 CRISPR and Genetic Engineering Molecular Biology 0 works
- 4 MicroRNA in disease regulation Cancer Research 0 works
- 5 DNA Repair Mechanisms Molecular Biology 0 works
- 6 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 7 Liver physiology and pathology Hepatology 0 works
- 8 Folate and B Vitamins Research Rheumatology 0 works
- 9 Voice and Speech Disorders Physiology 0 works
- 10 Neurological disorders and treatments Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Centro de Investigación Médica Aplicada's research output changed?
Other research institutions in Pamplona
- Universidad de Navarra
- Clinica Universidad de Navarra
- Universidad Pública de Navarra (UPNA)
- Departamento de Educación
- Departamento de Salud
- Complejo Hospitalario de Navarra
- Navarre Institute of Health Research
- Hospital Virgen del Camino
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.